We use cookies to understand how you use our site and to improve your experience. Please refer to our Terms and Conditions and Privacy Policy for more information about the cookies we use and how we protect your privacy.
Join us for "GVHD Diagnostics: Using the MAGIC Algorithm Probability (MAP) to guide Acute GVHD Treatment"
Presented by Drs. James Ferrara and Ryotaro Nakamura
2020 TCT Meetings in Orlando, Saturday, February 22th, 1:30 - 2:30 PM
Complete Diagnostics for Transplant Patients' Continuum of Care
What would it mean for patient care if you could streamline
transplant diagnostics to one lab?
LabAlert for Healthcare Providers
This is the next step in managing patient care.
A mobile app for keeping you informed during every stage of testing—
from sample status to lab reports—delivering the diagnostic information
you need faster to make treatment decisions.
Predict Risk of aGVHD and Non-Relapse Mortality
The First, Predictive Acute Graft vs Host Disease Algorithms with Clinically Validated Cutoffs for HCT Patients
TruGraf® Rules Out Silent Kidney Rejection.
A Game-Changing Alternative to Surveillance Biopsies
Now covered by Medicare, TruGraf® is the first biomarker-guided blood monitoring assay to rule out subclinical rejection for patients with stable renal function.
Connect with us